Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium; ; Br.E.A.S.T. Data Centre, Institut Jules Bordet, Brussels, Belgium.
J Thorac Dis. 2013 Jun;5 Suppl 1(Suppl 1):S81-6. doi: 10.3978/j.issn.2072-1439.2013.05.23.
Sexuality and sexual functioning is a cardinal domain of health-related quality of life in breast cancer patients, namely in the younger population. Young women below 40 years of age go through a time in their lives where sexual self-identity has recently matured, their professional obligations are demanding and they bear interpersonal and childbearing expectations, all of which can suffer a devastating turnaround with cancer diagnosis and its physical and psychological aftermath. Although these women's sexuality and directed interventions have remained largely unaddressed so far, concepts are evolving and treatment options are becoming diversified, chiefly on the field of non-hormonal pharmacological therapy of sexual dysfunction. This review will examine the definitions of female sexual dysfunction, the etiology of the disorders in young breast cancer patients, the assessment methods, the non-pharmacological and pharmacological treatment options and the challenges that lie ahead.
性行为和性功能是乳腺癌患者健康相关生活质量的重要领域,尤其是在年轻患者中。40 岁以下的年轻女性正处于性自我认同刚刚成熟、职业义务要求高、并承担人际关系和生育期望的时期,而癌症诊断及其身体和心理后果可能会使这一切遭受毁灭性的打击。尽管这些女性的性行为和针对性干预措施迄今在很大程度上尚未得到解决,但概念正在不断发展,治疗选择也在变得多样化,主要是在非激素药物治疗性功能障碍领域。这篇综述将探讨女性性功能障碍的定义、年轻乳腺癌患者障碍的病因、评估方法、非药物和药物治疗选择以及未来的挑战。